Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27

Ítems similars

• Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer
  per: Anderson, Stewart J., et al.
  Publicat: (2009)
• Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)
  per: Rastogi, Priya, et al.
  Publicat: (2017)
• Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
  per: Dignam, James J., et al.
  Publicat: (2008)
• Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! for Women with Node-Negative, ER-Positive Breast Cancer: Results from NSABP B-14 and NSABP B-20
  per: Tang, Gong, et al.
  Publicat: (2011)
• The Half Century of Clinical Trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)
  per: Wickerham, D. Lawrence, et al.
  Publicat: (2008)